Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Liabilities (2016 - 2025)

Lisata Therapeutics' Other Non-Current Liabilities history spans 13 years, with the latest figure at $72000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $72000.0; the TTM value through Dec 2025 reached $72000.0, changed 0.0%, while the annual FY2025 figure was $72000.0, 0.0% changed from the prior year.
  • Other Non-Current Liabilities reached $72000.0 in Q4 2025 per LSTA's latest filing, roughly flat from $72000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $337000.0 in Q1 2023 to a low of $72000.0 in Q3 2024.
  • Average Other Non-Current Liabilities over 3 years is $150833.3, with a median of $95500.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 71.54% in 2024, then changed 0.0% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $210000.0 in 2023, then tumbled by 65.71% to $72000.0 in 2024, then changed by 0.0% to $72000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Other Non-Current Liabilities are $72000.0 (Q4 2025), $72000.0 (Q3 2025), and $72000.0 (Q2 2025).